Home/Filings/4/0001181431-13-006299
4//SEC Filing

CROWLEY Richard 4

Accession 0001181431-13-006299

CIK 0000722104other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 1:57 PM ET

Size

4.8 KB

Accession

0001181431-13-006299

Insider Transaction Report

Form 4
Period: 2013-01-31
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
  • Sale

    Common Stock $.01 par value per share

    2013-01-31$1.02/sh2,415$2,463336,875 total
Footnotes (1)
  • [F1]These share were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax witholding obligations in connection with the vesting of restricted stock granted on May 24, 2011

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeother

Related Parties

1
  • filerCIK 0001352961

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 1:57 PM ET
Size
4.8 KB